Fundz

Immuno Genesis reported raising $44.4 Million in an initial SEC Form D filing, from an offering of $66.5 Million

PRIVATEApr 03, 2024

Amount Raised

$44.4 Million

$44.4 Million sold, per SEC Form D (first sale Mar 18, 2024)

Round Type

Venture

HoustonBiotechnology

Who to call at ImmunoGenesis, and when

A new round usually means ImmunoGenesis is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day ImmunoGenesis raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ImmunoGenesis, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ImmunoGenesis. With Fundz connected, it knows.

See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ImmunoGenesis

Location

2450 Holcombe Blvd, Suite J

Houston, Texas, United States

About

ImmunoGenesis is a clinical-stage immuno-oncology biopharmaceutical company re-envisioning the treatment of "cold" tumors, particularly of immune-excluded tumors. Immune-excluded tumors, which account for more than half of all cancers, are characterized by having mechanisms of resistance that suppress the immune response; this subgroup is resistant to current immunotherapies. ImmunoGenesis is creating therapies based on the pathology of these immune-excluded tumors that are rationally designed to overcome immune exclusion and thereby drive an effective immune response.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ImmunoGenesis raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for ImmunoGenesis's next move

See what Strategic adds

ImmunoGenesis raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.